The top 4 tumor-associated signaling pathways that were enriched in high-risk and low-risk groups were similar and consisted of TP53, RTK-RAS, NOTCH, and Hippo signaling pathways (Fig. 2D,E). This evidence concerns the gene TP53 and neoplasm.